Comparison of Acute and Subacute Genitourinary and Gastrointestinal Adverse Events of Radiotherapy for Prostate Cancer Using Intensity-modulated Radiation Therapy, Three-dimensional Conformal Radiation Therapy, Permanent Implant Brachytherapy and High-dose-rate Brachytherapy-Reference-Cited by-同舟云学术

Comparison of Acute and Subacute Genitourinary and Gastrointestinal Adverse Events of Radiotherapy for Prostate Cancer Using Intensity-modulated Radiation Therapy, Three-dimensional Conformal Radiation Therapy, Permanent Implant Brachytherapy and High-dose-rate Brachytherapy

Published:2014-05 Issue:3 Volume:100 Page:265-271
ISSN:0300-8916
Container-title:Tumori Journal
language:en
Short-container-title:Tumori Journal

Author:

Morimoto Masahiro¹²,Yoshioka Yasuo¹,Konishi Koji¹,Isohashi Fumiaki¹,Takahashi Yutaka³,Ogata Toshiyuki³,Koizumi Masahiko³,Teshima Teruki⁴,Bijl Henk P.²,van der Schaaf Arjen²,Langendijk Johannes A.²,Ogawa Kazuhiko¹

Affiliation:

1. Department of Radiation Oncology, Osaka University Graduate School of Medicine, Suita, Japan

2. Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

3. Division of Medical Physics, Oncology Center, Osaka University Hospital, Japan

4. Department of Medical Physics & Engineering, Osaka University Graduate School of Medicine, Suita, Japan

Publisher

SAGE Publications

Subject

Cancer Research,Oncology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1578.17198

Reference11 articles.

1. Radical External Beam Radiotherapy for Clinically Localized Prostate Cancer in Japan: Changing Trends in the Patterns of Care Process Survey

2. High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial

3. High-dose-rate brachytherapy as monotherapy for localized prostate cancer: A retrospective analysis with special focus on tolerance and chronic toxicity

4. Monotherapeutic High-Dose-Rate Brachytherapy for Prostate Cancer: Five-Year Results of an Extreme Hypofractionation Regimen With 54 Gy in Nine Fractions

5. Prostate Risk Index (PRIX) as a New Method of Risk Classification for Clinically Localized Prostate Cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute and late side-effects after low dose-rate brachytherapy for prostate cancer; incidence, management and technical considerations;Brachytherapy;2021-09

2. Complications and side effects of high-dose-rate prostate brachytherapy;Brachytherapy;2021-09

3. Prévention médicale et traitement des complications urologiques et néphrologiques secondaires à la radiothérapie;Cancer/Radiothérapie;2019-04

4. High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer;Radiotherapy and Oncology;2019-03

5. Lower urinary tract symptoms in patients with prostate cancer under and after intensity‐modulated radiation therapy;LUTS: Lower Urinary Tract Symptoms;2018-07-16